Can a pill shield celiac patients from accidental gluten?
NCT ID NCT05636293
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether the drug ritlecitinib could prevent intestinal damage and symptoms when people with celiac disease ate gluten. 62 adults with well-controlled celiac disease (on a gluten-free diet) took either the drug or a placebo along with a daily gluten challenge. The goal was to see if the drug could block the immune reaction and protect the gut lining.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CELIAC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a lesson in Gluten-Free eating boost Kids' health?
- Wheat sensitivity linked to fatty liver? a new study investigates
- Blood test plus symptom check may spare thousands from celiac biopsy
- Iron infusions may boost gut healing in celiac disease
- Massive spanish study maps celiac disease trends across generations
- Can a home gluten test help heal celiac disease?